Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Severity and Organ Dysfunction as Drivers of Mortality in Antimicrobial-Resistant <i>Acinetobacter baumannii</i> Pneumonia: A Retrospective Cohort Study.

Antibiotics (Basel, Switzerland)·2026
Same author

Multidrug-Resistant <i>Acinetobacter baumannii</i>: Resistance Mechanisms, Emerging Therapies, and Prevention-A Narrative Review.

Antibiotics (Basel, Switzerland)·2026
Same author

Multiorgan Involvement and Particularly Liver Injury in Long COVID: A Narrative Review.

Life (Basel, Switzerland)·2025
Same author

Hepatitis B virus associated with severe acute respiratory syndrome coronavirus 2 infection: a case report.

Journal of medical case reports·2025
Same author

COVID-19 Anxiety and Mental Health in Healthcare Workers: Examining the Role of Compassion Fatigue During the Last Wave of the Pandemic.

Psychiatry·2024
Same author

Stigma-associated attitudes and practices among Romanian clinical providers.

HIV medicine·2024

Related Experiment Video

Updated: Jun 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Statins and endothelial dysfunction].

Florina-Mihaela Filip-Ciubotaru1, Carmen Manciuc, Liliana Foia

  • 1Disciplina de Medicina Familiei, Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr.T. Popa". Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|March 3, 2010
PubMed
Summary

Statins offer significant cholesterol-independent benefits, known as pleiotropic effects. These include improved endothelial function, antioxidant, and anti-inflammatory actions, expanding their therapeutic potential beyond lipid lowering.

Related Experiment Videos

Last Updated: Jun 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Biochemistry

Context:

  • Statins are primarily known for cholesterol reduction.
  • Emerging evidence highlights their diverse cholesterol-independent effects, termed pleiotropic benefits.

Purpose:

  • To elucidate the multifaceted pleiotropic mechanisms of statins.
  • To explore the therapeutic implications of these non-lipid-lowering effects.

Summary:

  • Statins improve endothelial dysfunction by increasing nitric oxide (NO) bioavailability.
  • They reduce inflammatory markers by modulating cytokine production and decreasing adhesion molecule expression.
  • Statins exhibit antioxidant properties, reducing superoxide radical anion production.

Impact:

  • Understanding these mechanisms can lead to novel therapeutic strategies for cardiovascular diseases and dyslipidemia.
  • Statins may be repurposed for conditions beyond their current indications.
  • This knowledge enhances the clinical application of statins in complex pathological states.